| ▲ | ck2 7 hours ago | |
previous coverage before it was approved, explaining the superiority * https://www.theatlantic.com/health/archive/2023/10/xocova-en... * https://nypost.com/2023/10/26/health/why-covid-sufferers-in-... Differences in Treatment Patterns and Patient Characteristics Between COVID-19 Patients Treated with Nirmatrelvir/Ritonavir and Ensitrelvir in Japan | ||